FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models. [electronic resource]
- Neuroscience Jan 2012
- 396-404 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-7544
10.1016/j.neuroscience.2011.11.036 doi
Adaptor Proteins, Signal Transducing Animals Benzeneacetamides--pharmacology Blotting, Western Cell Line Chromones--pharmacology Corpus Striatum--drug effects DNA-Binding Proteins--biosynthesis Dopamine--metabolism Dopaminergic Neurons--drug effects Flow Cytometry Immunohistochemistry Immunoprecipitation MPTP Poisoning--drug therapy Male Mice Mice, Inbred C57BL Morpholines--pharmacology Movement Disorders--drug therapy Neuroprotective Agents Oncogene Protein v-akt--physiology Phenols--pharmacology Postural Balance--drug effects Protein Kinase Inhibitors--pharmacology Proto-Oncogene Proteins c-akt--antagonists & inhibitors Signal Transduction--drug effects TOR Serine-Threonine Kinases--physiology Transcription Factors--biosynthesis Tyrosine 3-Monooxygenase--metabolism alpha-Synuclein--drug effects